Stefan H. E. Kaufmann, PhD, is founding director of the Max Planck Institute for Infection Biology, Berlin, Germany, where he heads the Department of Immunology. He is also Professor for Microbiology & Immunology at the Charité, Berlin and Doctor Honoris Causa from the Université de la Mediterranée, Marseille, France. He is former President of the German Society for Immunology and the European Federation of Immunological Societies, and Past President of the International Union of Immunological Societies. He is interested in immunity to tuberculosis (TB) and rational vaccine and biomarker design. He has co-developed a TB vaccine candidate which has completed a phase II-clinical trial. He thus tries to combine basic and applied research with a focus on mycobacterial ligands that stimulate innate immunity, mechanisms underlying antigen presentation, apoptosis and autophagy in TB and the role of cytokines and chemokines as well as T cells and myeloid cells in pathogenesis and protection in TB.
« Go Back